64
Views
5
CrossRef citations to date
0
Altmetric
Original

Efficacy of Inhaled Budesonide and Oral Theophylline in Asthmatic Subjects

, M.D., , , M.D., , M.D., , M.D. & , M.D.
Pages 673-679 | Published online: 31 Dec 2001

REFERENCES

  • Cockcroft D. W. Therapy for Airway Inflammation in Asthma. J. Allergy Clin. Immunol. 1991; 87: 914–919
  • Busse W. W., Calhoun W. F., Sedgewick J. D. Mechanism of Airway Inflammation in Asthma. Am. Rev. Respir. Dis. 1993; 147: S20–S24
  • Djukanovic R., Wilson J. W., Britten K. M., Wilson S. J., Walls A. F., Roche W. R., Howarth P. H., Holgate S. T. Effect of an Inhaled Corticosteroid on Airway Inflammation and Symptoms in Asthma. Am. Rev. Respir. Dis. 1992; 145: 669–674
  • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 1995, NHLBI/WHO Workshop Report 95–3659;
  • Beasley R., Roche W. R., Robert J. A., Holgate S. T. Cellular Events in the Bronchi in Mild Asthma and After Bronchial Provocation. Am. Rev. Respir. Dis. 1989; 139: 806–817
  • Bradley B. L., Azzawi M., Jacobson M., Assoufi B., Collins J. V., Irani A. M., Schwartz L. B., Durham S. R., Jeffery P. K., Kay A. B. Eosinophils, T-lymphocytes, Mast Cells, Neutrophils and Macrophages in Bronchial Biopsies from Atopic Asthma: Comparison with Atopic Non-Asthma and Normal Controls and Relationship to Bronchial Hyperresponsiveness. J. Allergy Clin. Immunol. 1991; 88: 661–674
  • Walker C., Kaegi M. K., Braun P., Blasser K. Activated T Cells and Eosinophilia in Bronchoalveolar Lavages from Subjects with Asthma Correlated with Disease Severity. J. Allergy Clin. Immunol. 1991; 88: 935–942
  • Bousquet J., Chanez P., Lacoste J. Y., et al. Eosinophilic Inflammation in Asthma. N. Engl. J. Med. 1990; 323: 1033–1039
  • Ackerman V., Marini M., Vittori E., Bellini A., Vassali G., Mattoli S. Detection of Cytokines and Their Cell Sources in Bronchial Biopsy Specimens from Asthmatic Patients. Chest 1994; 105: 687–696
  • Sanjiv S., Gleich G. J., Swanson M. C., Bartemes K. R., Broide D. H. Eosinophilic Inflammation Is Associated with Elevation of Interleukin-5 in the Airways of Patients with Spontaneous Symptomatic Asthma. J. Allergy Clin. Immunol. 1995; 96: 661–668
  • U.S.Department of Health and Human Services. International Consensus Report on Diagnosis and Treatment of Asthma, U.S. Department of Health and Human Services, Washington, DC, March, 1992, U.S. DHHS Publication No. 92–3091;
  • British Thoracic Society Guidelines on the Management of Asthma. Thorax 1993; 48: S1–S24, (suppl)
  • Robinson D., Hamid Q., Ying S., Bentley A., Assoufi B., Durham S., Kay A. B. Prednisolone Treatment in Asthma Is Associated with Modulation of Bronchoalveolar Lavage Cell Interleukin-4, Interleukin-5, and Interferon-γ Cytokine Gene Expression. Am. Rev. Respir. Dis. 1993; 148: 401–406
  • Barnes P. J. Inhaled Glucocorticoids for Asthma. N. Engl. J. Med. 1995; 332: 868–875
  • Mellis C. M., Peat J. K., Woolcock A. J. The Costs of Asthma: Can It Be Reduced?. Pharmacoeconomics. 1993; 3: 205–219
  • Spector S. Noncompliance with Asthma Therapy—Are There Solutions. J. Asthma. 2000; 37: 381–388
  • Arkinstall W. W., Atkins M. E., Harrison D., Stewart J. H. Once-Daily Sustained Release Theophylline Reduces Diurnal Variation in Spirometry and Symptomatology in Adult Asthmatics. Am. Rev. Respir. Dis. 1987; 135: 316–321
  • Nassif E. G., Weinberger M., Thompson R., Huntley W. The Value of Maintenance Theophylline in Steroid-Dependent Asthma. N. Engl. J. Med. 1981; 304: 71–75
  • Kidney J., Dominguez M., Taylor P. M., Rose M., Chung K. F., Barnes P. J. Immunomodulation by Theophylline in Asthma: Demonstration by Withdrawal of Therapy. Am. J. Respir. Crit. Care Med. 1995; 51: 1907–1914
  • Ward A. J.M., McKenniff M., Evans J. M., Page C. P., Costello J. F. Theophylline—An Immunomodulatory Role in Asthma?. Am. Rev. Respir. Dis. 1993; 147: 518–523
  • Sullivan P., Bekir S., Jaffar Z., Page C., Jeffery P., Costello J. Anti-inflammatory Effects of Low-Dose Oral Theophylline in Atopic Asthma. Lancet 1994; 343: 1006–1008
  • American Thoracic Society. Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and Asthma. Am. Rev. Respir. Dis. 1987; 136: 225–244
  • Finnerty J. P., Lee C., Wilson S., Madden J., Djukanovic R., Holgate S. T. Effects of Theophylline on Inflammatory Cells and Cytokines in Asthmatic Subjects: A Placebo-Controlled Parallel Group study. Eur. Respir. J. 1996; 9: 1672–1677
  • Lundback B., Rawliason D. W., Palmer J. B.D. Twelve Months Comparison of Salmeterol and Salbutamol as Dry Powder Formulations in Asthmatic Patients. Thorax 1993; 48: 148–153
  • Laitinen L. A., Laitinen A., Haahtela T. A. A Comparative Study of the Effects of an Inhaled Corticosteroid, Budesonide, and of a β2-agonist, Terbutaline, on Airway Inflammation in Newly Diagnosed Asthma: A Randomized, Double-Blind, Parallel-Group Controlled Trial. J. Allergy Clin. Immunol. 1992; 90: 32–42
  • Saetta M., Di Stefano A., Maestrelli P., Turato G., Mapp C. E., Pieno M., Zanguochi G., Del Prete G., Fabbri L. M. Airway Eosinophilia and Expression of IL-5 Protein in Asthma and in Exacerbations of Chronic Bronchitis. Clin. Exp. Allergy. 1996; 26: 766–774
  • Corrigan C. J., Haczku A., Gemou-Engesaeth V., Doi S., Kikuchi Y., Takatsu K., Durham S. R., Kay A. B. CD4 T-Lymphocyte Activation in Asthma Is Accompanied by Increased Serum Concentrations of Interleukin-5: Effect of Glucocorticoid Therapy. Am. Rev. Respir. Dis. 1993; 147: 540–547
  • Rivington R. N., Boulet L. P., Cote J., Kreisman H., Small D. I., Alexander M., Day A., Harsanyi Z., Darke A. C. Efficacy of Uniphyl, Salbutamol, and Their Combination in Asthmatic Patients on High-Dose Inhaled steroids. Am. J. Respir. Crit. Care Med. 1995; 151: 325–332
  • Evans D. J., Taylor D. A., Zetterstrom O., Chung K. F., O'Connor B. J., Barnes P. J. A Comparison of Low-Dose Inhaled Budesonide Plus Theophylline and High-Dose Inhaled Budesonide for Moderate Asthma. N. Engl. J. Med. 1997; 337: 1412–1418
  • Barnes P. J., Jonsson B., Klim J. P. The Cost of Asthma. Eur. Respir. J. 1996; 9: 636–642
  • Weinberger M., Hendeles L. Theophylline in Asthma. N. Engl. J. Med. 1996; 334: 1380–1388
  • Fireman P. Combination of Inhaled Corticosteroids Plus Other Medications in the Management of Moderate to Severe Persistent Asthma. Allergy Asthma Proc. 2000; 21: 315–322
  • Tinkelman D. G., Reed C. E., Nelson H. S., Offord K. P. Aerosol Beclomethasone Dipropionate Compared with Theophylline as Primary Treatment of Chronic, Mild to Moderately Severe Asthma in Children. Pediatrics. 1993; 92: 64–77
  • Shannon M. Life-Threatening Events After Theophylline Overdose: A 10-Year Prospective Analysis. Arch. Intern. Med. 1999; 159: 989–994
  • Self T. H., Chafin C. C., Soberman J. E. Effect of Disease States on Theophylline Serum Concentrations: Are We Still Vigilant?. Am. J. Med. Sci. 2000; 319: 177–182
  • Stead R. J., Cooke N. J. Adverse Effects of Inhaled Corticosteroids. Br. Med. J. 1989; 298: 403–404

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.